Fractyl Health (GUTS) Other Non Operating Income (2023 - 2026)
Fractyl Health's (GUTS) quarterly Other Non Operating Income came in at -$11000.0 in Q4 2025, down 10.0% YoY from -$12222.2 in Q4 2024, and down 83.33% on a QoQ basis from -$6000.0 in Q3 2025.
Fractyl Health (GUTS) Other Non Operating Income (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 3 years of Other Non Operating Income data on file, last reported at -$11000.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 10.0% year-over-year to -$11000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$53000.0 (down 12.77% YoY) and the FY2025 annual result came in at -$53000.0, down 12.77% from the prior year.
- Other Non Operating Income fell to -$11000.0 in Q4 2025, from -$6000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9000.0 in Q1 2023 to a low of -$21000.0 in Q1 2025.
- A 3-year average of -$10333.3 and a median of -$10000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income sank 211.11% — and 2025, when it soared 33.33%.
- Tracing GUTS's Other Non Operating Income over 3 years: stood at -$8000.0 in 2023, then retreated by 25.0% to -$10000.0 in 2024, then declined by 10.0% to -$11000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$11000.0 (Q4 2025), -$6000.0 (Q3 2025), and -$15000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7,000.00 |
| Dec 31, 2025 | -11,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -10,000.00 |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -18,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -17,000.00 |
| Mar 31, 2023 | 9,000.00 |